MétaCan
Menu
Back to cohort
Record W2310110904

Hydroxyapatite-coated cardiovascular stents.

2006· article· en· W2310110904 on OpenAlexaffabout
Anna Rajtar, Kaluza Gl, Qiuwei Yang, D Hakimi, Liu D, Manus Pui-Hung Tsui, Mary H Lien, Doug Smith, Clubb Fj, T Troczynski

Bibliographic record

VenuePubMed · 2006
Typearticle
Languageen
FieldEngineering
TopicBone Tissue Engineering Materials
Canadian institutionsAcuitas Therapeutics (Canada)
Fundersnot available
KeywordsMedicineBiocompatibilityCoatingStentDrug deliveryBiomedical engineeringSurgeryNanotechnologyMaterials scienceMetallurgy
DOInot available

Abstract

fetched live from OpenAlex

Description and history Extensive clinical practice supported with evidence gathered during numerous animal studies has shown that in addition to its excellent biocompatibility, hydroxyapatite (HAp, a crystalline derivative of calcium phosphate) is non-toxic and does not induce allergic or inflammatory reactions. The latest research on HAp appears to confirm that HAp crystals “do not acquire a pro-inflammatory or thrombogenic phenotype, but express markers of functioning endothelium that might contribute to angiogenesis.”1 The new generation of non-polymeric drug-eluting cardiovascular stents (as compared to polymer-coated stents) is expected to offer drug delivery solutions which will be less thrombogenic and more tolerable by the body environment (less restenotic) while, at the same time, capable of delivering the desired quantity of drugs in a manner that reflects recommendations of scientists, and responding to the reallife needs and abilities of the patient. These generic observations prompted MIV Therapeutics Inc. to consider HAp as a coating suitable for drug delivery on cardiovascular stents. Such HAp coated stents are being developed within the collaborative research and development program between University of British Columbia, and MIV Therapeutics Inc., both located in Vancouver, BC, Canada. The challenge is that the brittleness of ceramic HAp coating has to withstand deformation during stent crimping and implantation, and remain undamaged and biologically inert years after the implantation into arteries of human heart. In response to this challenge, several novel coating technologies have been developed in 20032005 for deposition of HAp ceramics on stents and other implantable medical devices, by combined efforts and ingenuity of the teams of MIV Therapeutics, Inc. and University of British Columbia. Technical specifications “Wet” chemical technologies were used for deposition of ultra-thin (0.1-0.2 μm) and micro-thin (0.3-1.0 μm) HAp coatings. The ultrathin films composed of high-density non-porous hydroxyapatite are designated primarily as a biocompatible surface modification of metallic implants, whereas the micro-thin films which possess highly porous structure were developed and evaluated also as a potential vehicle for effective and highly engineerable drug delivery. The deposition of the 0.1-0.2 μm ultra-thin films of HAp ceramics used sol-gel (SG) subjected to heat treatment at 450°C which ensured their structural integrity and necessary mechanical properties. The resulting SG-HAp Class “0” ultra-thin “passive” (drug-free) coatings are very well bonded to metal substrates such as stainless steel or Co-Cr alloys, feature acceptably smooth surface (Figure 1) and survive undamaged the stent crimping-implanting-expansion proce-

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.884
Threshold uncertainty score0.672

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.147
Teacher spread0.139 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations33
Published2006
Admission routes2
Has abstractyes

Explore more

Same venuePubMedSame topicBone Tissue Engineering MaterialsFrench-language works237,207